Evidence map›Paper›PMID 34836521›Full record

Observational studyBMC public health2021

Impact of socio-economic factors on Tuberculosis treatment outcomes in north-eastern Uganda: a mixed methods study.

Jasper Nidoi, Winters Muttamba, Simon Walusimbi, Joseph F Imoko, Peter Lochoro, Jerry Ictho, Levicatus Mugenyi, Rogers Sekibira, Stavia Turyahabwe, Raymond Byaruhanga and 4 more

Abstract readObservational Study
In one paragraph

Observational study in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jasper NidoiMakerere University Lung Institute (MLI), Kampala, Uganda. jjnidoi@gmail.com.
Winters MuttambaMakerere University Lung Institute (MLI), Kampala, Uganda.
Simon WalusimbiMakerere University Lung Institute (MLI), Kampala, Uganda.
Joseph F ImokoMakerere University Lung Institute (MLI), Kampala, Uganda.
Peter LochoroDoctors with Africa CUAMM, Kampala, Uganda.
Jerry IcthoDoctors with Africa CUAMM, Kampala, Uganda.
Levicatus MugenyiMakerere University Lung Institute (MLI), Kampala, Uganda.
Rogers SekibiraMakerere University Lung Institute (MLI), Kampala, Uganda.
Stavia TuryahabweNational Tuberculosis and Leprosy Control Program (NTLP), Kampala, Uganda.
Raymond ByaruhangaNational Tuberculosis and Leprosy Control Program (NTLP), Kampala, Uganda.
Giovanni PutotoDoctors with Africa CUAMM, Padova, Italy.
Simone VillaCentre for Multidisciplinary Research in Health Science, University of Milan, Milan, Italy.
Mario C RaviglioneCentre for Multidisciplinary Research in Health Science, University of Milan, Milan, Italy.
Bruce KirengaMakerere University Lung Institute (MLI), Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) is a major public health problem and at 48%, Karamoja in North-Eastern Uganda has the lowest treatment success rate nationally. Addressing the social determinants of TB is crucial to ending TB. This study sought to understand the extent and ways in which socio-economic factors affect TB treatment outcomes in Karamoja.

methodsWe conducted a convergent parallel mixed methods study in 10 TB Diagnostic and Treatment Units. The study enrolled former TB patients diagnosed with drug-susceptible TB between April 2018 and March 2019. Unit TB and laboratory registers were reviewed to identify pre-treatment losses to follow-up. Four focus group discussions with former TB patients and 18 key informant interviews with healthcare workers were conducted. Principle component analysis was used to generate wealth quintiles that were compared to treatment outcomes using the proportion test. The association between sociodemographic characteristics and TB treatment outcomes was evaluated using the chi-square test and multiple logistic regression.

resultsA total of 313 participants were randomly selected from 1184 former TB patients recorded in the unit TB registers. Of these, 264 were contacted in the community and consented to join the study: 57% were male and 156 (59.1%) participants had unsuccessful treatment outcomes. The wealthiest quintile had a 58% reduction in the risk of having an unsuccessful treatment outcome (adj OR = 0.42, 95% CI 0.18-0.99, p = 0.047). People who were employed in the informal sector (adj OR = 4.71, 95% CI 1.18-18.89, p = 0.029) and children under the age of 15 years who were not in school or employed (adj OR = 2.71, 95% CI 1.11-6.62, p = 0.029) had significantly higher odds of unsuccessful treatment outcome. Analysis of the pre-treatment loss to follow-up showed that 17.2% of patients with pulmonary bacteriologically confirmed TB did not initiate treatment with a higher proportion among females (21.7%) than males (13.5%). Inadequate food, belonging to migratory communities, stigma, lack of social protection, drug stock-outs and transport challenges affected TB treatment outcomes.

conclusionsThis study confirmed that low socio-economic status is associated with poor TB treatment outcomes emphasizing the need for multi- and cross-sectoral approaches and socio-economic enablers to optimise TB care.

Indexed as

TuberculosisTuberculosis, PulmonaryAdolescentChildEconomic FactorsFemaleHumansMaleSocioeconomic FactorsTreatment OutcomeUgandaDeterminants of healthSocio-economic factorsTuberculosis treatment outcomes

Identifiers

PMID34836521
PMCPMC8620143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.